Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Gene test could guide use of cancer chemotherapy
A gene test already used routinely in the NHS can guide use of chemotherapy in people with bowel cancer by predicting whether or not they will benefit.
New study unveils epigenetic ‘traffic lights’ controlling stop and go for gene activity
A major new study in the journal Nature reveals a ‘traffic light’ mechanism controlling genetic activity within cells – a system which could potentially be targeted by cancer drugs already in development.
Expectations for population-wide gene testing need to be realistic, say researchers
Testing a population for multiple genes at once will always be limited in its ability to accurately predict disease risk, experts are warning.
Scientists reveal how different cancer cells ‘team up’ to help incurable childhood brain tumour spread
Scientists have shed light on how different types of cancer cells in an aggressive childhood brain cancer interact and work together to spread.
‘Molecular glue degrader’ reaches cancer trial following ICR research programme
The biotechnology company Monte Rosa Therapeutics – originally a spin-out from research at The Institute of Cancer Research, London – has announced that the first patient has received their ‘molecular glue degrader’ drug as part of a clinical trial in oncology.
Meet our scientists at upcoming industry collaboration events
Upcoming events will give industry experts the chance to hear from some of our leading researchers about opportunities to work with them.
Urinary and sexual side effects less likely after advanced radiotherapy than surgery for advanced prostate cancer patients
Men with prostate cancer are less likely to experience urinary and sexual side effects two years after treatment with an advanced type of radiotherapy than surgery, according to researchers from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.
Mobile health checks could speed up diagnosis of prostate cancer
Data from a pilot study suggestthe ‘Man Van’, an innovative targeted outreach programme, could improve healthcare access for men and potentially speed up the detection of prostate cancer.
Strong family history of prostate cancer linked to better survival
Being aware of a strong family history of prostate cancer is linked to an increased chance of surviving the disease, new research suggests.
Researchers discover potential new series of cancer drugs targeting cancer-driving protein BCL6
Scientists have revealed details of the discovery of new inhibitors of the BCL6 protein, which is involved in driving several cancer types including the blood cancer B-cell lymphoma.
Drug discovery researcher Professor Paul Workman awarded prestigious AAAS Fellowship
Professor Paul Workman, former Chief Executive and President of The Institute of Cancer Research, London, from 2014 to 2021, has been elected as a Fellow of the American Association for the Advancement of Science (AAAS), one of the most distinguished honours in the scientific community.
Experts call for better cancer tests to tailor treatment
Greater use of cancer tests is the key to tailoring use of new treatments for patients more precisely and so increasing their chances of being recommended for use within the NHS, experts say.